Details for New Drug Application (NDA): 065010
✉ Email this page to a colleague
NDA 065010 describes NEO-FRADIN, which is a drug marketed by X Gen Pharms and is included in one NDA. Additional details are available on the NEO-FRADIN profile page.
The generic ingredient in NEO-FRADIN is neomycin sulfate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
The generic ingredient in NEO-FRADIN is neomycin sulfate. There are nineteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
Summary for 065010
| Tradename: | NEO-FRADIN |
| Applicant: | X Gen Pharms |
| Ingredient: | neomycin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065010
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | EQ 87.5MG BASE/5ML | ||||
| Approval Date: | May 23, 2002 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
